The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results
Abstract
Background—: Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study was designed to compare the 12-month safety and effectiveness of a polymer-free, paclitaxel-coated nitinol drug-eluting stent (DES) with percutaneous transluminal angioplasty (PTA) and provisional bare metal stent (BMS) placement in patients with femoropopliteal peripheral artery disease. Methods and Results—: Patients were randomly assigned to primary DES implantation (n=236) or PTA (n=238). Demographics and lesion characteristics were similar between groups (eg, average lesion length, approximately 65±40 mm). One hundred twenty patients had acute PTA failure and underwent secondary random assignment to provisional DES (n=61) or BMS (n=59). Primary end points were the 12-month rates of event-free survival and patency in the primary DES and PTA groups. Compared with the PTA group, the primary DES group exhibited superior 12-month event-free survival (90.4% versus 82.6%; P =0.004) and primary patency (83.1% versus 32.8%; P <0.001), satisfying the primary hypotheses. In the secondary evaluations, (1) the primary DES group exhibited superior clinical benefit compared with the PTA group (88.3% versus 75.8%; P <0.001), (2) the provisional DES group exhibited superior primary patency (89.9% versus 73.0%; P =0.01) and superior clinical benefit (90.5% and 72.3%, P =0.009) compared with the provisional BMS group, and (3) the stent fracture rate (both DES and BMS) was 0.9% (4/457). Conclusions—: Femoropopliteal peripheral artery disease treatment with the paclitaxel-eluting stent was associated with superior 12-month outcomes compared with PTA and provisional BMS placement. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00120406.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
Schillinger, M., Sabeti, S., Loewe, C., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., Cejna, M., Lammer, J., & Minar, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051303 · Cited by 1,157
Prevalence and clinical impact of stent fractures after femoropopliteal stenting
Scheinert, D., Scheinert, S., Sax, J., Piorkowski, C., Bräunlich, S., Ulrich, M., Biamino, G., & Schmidt, A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.026 · Cited by 886
van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M. M., Serruys, P. W., Holmes, D. R., Ellis, S. G., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.94.7.1690 · Cited by 852
Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg
Tepe, G., Zeller, T., Albrecht, T., Heller, S., Schwarzwälder, U., Beregi, J.-P., Claussen, M. D. C. D., Oldenburg, A., Scheller, B., & Speck, U. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706356 · Cited by 803
Self-citationAxel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O’Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127110.49192.72 · Cited by 759
Cited by
Global Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
Self-citationKatsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M., & Karnabatidis, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011245 · Cited by 1,020
Conte, M. S., Pomposelli, F. B., Clair, D. G., Geraghty, P. J., McKinsey, J. F., Mills, J. L., Moneta, G. L., Murad, M. H., Powell, R. J., Reed, A. B., et al. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.12.009 · Cited by 921
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Rosenfield, K., Jaff, M. R., White, C. J., Rocha-Singh, K., Mena-Hurtado, C., Metzger, D. C., Brodmann, M., Pilger, E., Zeller, T., Krishnan, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406235 · Cited by 686
Self-citation
Metadata
- Authors
- Dake, M. D., Ansel, G. M., Jaff, M. R., Ohki, T., Saxon, R. R., Smouse, H. B., Zeller, T., Roubin, G. S., Burket, M. W., Khatib, Y., Snyder, S. A., Ragheb, A. O., White, J. K., & Machan, L. S.
- Venue
- Circulation: Cardiovascular Interventions
- Published
- 2011-10
- Volume
- 4
- Issue
- 5
- Pages
- 495-504
- ISSN
- 1941-7632 (ISSN-L)
- 1941-7640
- OpenAlex
- W2887208783
- Cited by
- 569
- References
- 25
- FWCI
- 43.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results. https://app.cochat.ai/papers/10.1161/circinterventions.111.962324
- The paper
- Dake, M. D., Ansel, G. M., Jaff, M. R., Ohki, T., Saxon, R. R., Smouse, H. B., Zeller, T., Roubin, G. S., Burket, M. W., Khatib, Y., Snyder, S. A., Ragheb, A. O., White, J. K., & Machan, L. S. (2011). Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.111.962324
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.